Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA delays action on paediatric OTC cough/cold medicines

This article was originally published in Scrip

Executive Summary

The US FDAhas decided against taking immediate action to restrict the use of over-the-counter cough/cold medicines by children older than two years. Instead the agency will hold a public hearing on the types of safety and efficacy data needed to support the products' use by children as it embarks on a lengthy rulemaking process.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC007170

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel